Coala-Life Group AB is a cloud-based Software as a Service (SaaS) provider also developing and marketing medical equipment, primarily Coala Heart Monitor.
The company focuses on B2B-solutions for distance monitoring of chronically ill patients (managed Remote Patient Monitoring) and offers caregivers in the US a scalable and cost efficient platform for monitoring large volumes of patients suffering from chronic conditions. Patients monitored by Coala Life often suffer from diabetes, overweight and/or cardiovascular diseases. The operations in the USA are managed through the subsidiary QorumPartners.
Coala Life was founded 2015 and the share is, as of November 2021, publicly traded on Nasdaq First North Growth Market (ticker: COALA.ST).
